{"id":"W2158202057","doi":"10.1016/s0140-6736(12)61768-1","title":"Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1193,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; NeuroRx Research (Canada)","funders":"National Institutes of Health; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Alemtuzumab; Multiple sclerosis; Medicine; Randomized controlled trial; Disease; Internal medicine; Physical therapy; Oncology; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002826242,0.002625882,0.004782395,0.000476492,0.0008410452,0.00165735,0.001137859,0.003304572,0.005947256],"category_scores_gemma":[0.003034679,0.0007712627,0.004201819,0.000690788,0.001662343,0.001504796,0.0007605256,0.003612358,0.001013678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001199592,"about_ca_system_score_gemma":0.001628749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001785198,"about_ca_topic_score_gemma":0.002590137,"domain_scores_codex":[0.9986725,0.0007121228,0.00009014941,0.0002044592,0.00008394071,0.0002369356],"domain_scores_gemma":[0.998387,0.0004893468,0.0004059544,0.0001786481,0.00009426195,0.0004448386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9897938,0.001209729,0.0004245484,0.000457439,0.001441638,0.00004142349,0.00004327244,0.0001261702,0.0009303546,0.00006561181,0.0004439271,0.005022133],"study_design_scores_gemma":[0.9870518,0.01089659,0.0008569244,0.00002815872,0.0006046404,0.00001882312,0.00001080437,0.00006385466,0.00007657569,0.00008993569,0.0002939951,0.000007812567],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747816,0.01417418,0.0008082475,0.001901596,0.001203336,0.003581666,0.001378144,0.0001340334,0.00203725],"genre_scores_gemma":[0.9802687,0.005367537,0.001601771,0.002393248,0.0009139276,0.004836289,0.001335019,0.00003214656,0.003251396],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005947256,"threshold_uncertainty_score":0.01989555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1151705557353955,"score_gpt":0.3443890657103396,"score_spread":0.2292185099749441,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}